SERIOUS
(G)
Actual Harm - a resident was hurt due to facility failures
Quality of Care
(Tag F0684)
A resident was harmed · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, record review, and document review, the facility failed to ensure two of 34 sampled residents (...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, record review, and document review, the facility failed to ensure two of 34 sampled residents (Resident Identifier (RI) #74 and RI #69) received nursing care and services in accordance with physician's orders and/or care plans. RI#74 had significant scaly, scabbed, psoriasis noted on the skin of his/her scalp, back, and legs/feet. The skin assessments did not accurately record the resident's skin condition and a medicated cream prescribed by the physician was not implemented. RI #69 had a recent history of a fecal impaction. The resident complained of severe constipation during the survey. Staff failed to monitor and document his/her bowel movements to ensure he/she was not constipated.
Findings include:
1. Review of the undated admission Record, in the electronic medical record (EMR) under the Profile tab revealed RI#74 was admitted to the facility on [DATE] with diagnoses including unspecified dementia without behavioral disturbance, mixed incontinence, hypertension, pain, weakness, and psoriasis.
Review of the paper copy of the hospital History and Physical in the resident's chart, dated 06/27/19, revealed RI#74 had a history of psoriasis with an improvement noted to his/her back after starting Humira (immunosuppressive medication used to treat psoriasis) approximately one year ago. The resident was admitted to the nursing home following this hospitalization.
Review of the Clinical Physician's Orders in the EMR under the Orders tab revealed RI #74 was admitted to hospice on 05/19/20.
Review of the Significant Change Minimum Data Set (MDS) with an assessment reference date (ARD) of 06/26/20, located in the EMR under the MDS tab, revealed the resident did not speak, rarely/never made him/herself understood, rarely/never understood others, and was unable to complete the Brief Interview for Mental Status (BIMS) test. The resident was severely impaired in cognitive skills for decision making. The diagnosis of psoriasis was documented on the MDS.
Review of the Care Plan dated 09/22/20, in the EMR under Care Plan tab, documented the resident's diagnosis of psoriasis. Care plan interventions included in pertinent part provision of comfort care, medication as ordered, and monitor and treat the resident's skin.
Review of the Physician's Orders dated 05/03/21, in the paper chart under the Orders section, revealed an order was written on this date for Triamcinolone (steroid ointment used to relieve redness, itching, swelling and discomfort caused by skin conditions such as psoriasis) .5% twice daily to affected areas for psoriasis.
Review of the Clinical Physician Orders current 06/22/21 in the EMR under the Orders tab revealed no current order for Triamcinolone.
Review of the Treatment Administration Record Report for the month of June 2021 in the EMR under the Orders tab revealed no order or administration of Triamcinolone.
Review of the weekly Total Body Skin Assessments dated 04/01/21, 04/08/21, 04/22/21, 04/29/21, 05/06/21, 05/13/21, 05/20/21, 05/27/21, 06/03/21, 06/10/21, 06/17/21, in the EMR under the Assessment tab, all revealed RI #74's skin had good elasticity, was normal in color, was warm in temperature, with normal moisture, and normal in condition (degree of dryness -oiliness).
During an interview on 06/22/21 at 2:25 PM, RI #74's family member stated he/she went to see RI #74 on 06/03/21 and the resident was crying. RI #74's family member stated that he/she asked for medicine (for pain), adding, I did not know the psoriasis came back so bad. He/she stated the resident's skin itched, got scratched, which made sores. RI #74's family member stated the resident could not move his/her arms; they were crossed (contracted), but he/she tried to scratch the psoriasis. He/she stated the resident's physician had ordered some cream to treat the resident's psoriasis.
Observation on 06/21/21 at 3:16 PM resident was in bed and the top part of the resident's back was visible and was observed with scaly, white, dry, flaky skin; the resident's scalp near the hairline also had significant white, crusty, matter attached to the hair follicles.
Observation on 06/22/21 at 11:21 AM, the resident was positioned in bed. Small pieces of what looked like grey lint (which was dead skin) covered the bottom sheet/bedding.
Observation on 06/23/21 at 11:25 AM, the resident was lying in bed. The resident's scalp had a scaly, crusty, white substance visible along the hairline.
On 06/23/21 at 1:15 PM, the resident's skin was observed with RI #74's family member and Employee Identifier (EI) #20 Registered Nurse (RN). The resident was turned on his/her side and the resident's back had numerous areas of dry, flaky skin and scabbed areas. The resident's scalp at the hairline had thick, white, flaky, scabby matter. RI #74's family member said when he/she tried to remove it (white flaky matter), the resident's hair pulled out with the flaky, scabby, white matter. There was flaky skin on the front of the resident's legs and his/her feet had scabbed flaky areas. There was a significant amount of grey dead skin covering the resident's bedding.
On 6/24/21 at 9:25 AM the resident's skin was observed by EI #12, Licensed Practical Nurse (LPN). Both of the resident's lower extremities were noted to have profoundly dry flaky skin from the resident's feet to the knees with dead skin observed throughout the sheets and on the resident's clothing. The skin was open with a shallow scratch and probably due to the resident scratching his/her leg with his/her right foot. The resident's hands were contracted and he/she couldn't reach his/her shin to scratch with his/her hands. There were also areas of psoriatic/extremely dry skin on his/her scalp and on his/her back just below the hairline about 2-3 cm area at hairline and scattered areas on the lower back and under the arms/shoulders.
During an interview on 06/23/21 at 11:38 AM, EI #23, Certified Nursing Assistant stated RI #74 required total care. EI #23 stated the resident had a skin condition, scabbing sores, and he/she, greased her down good using barrier cream (skin cream intended to maintain the skin's physical barrier, providing protection from irritants and drying out).
During an interview on 06/23/21 at 12:38 PM, EI #20 stated the resident was treated with adalimumab (Humira) prior to the initiation of hospice on 05/19/20. She stated the medication could not be continued due to financial reasons, stating Medicaid did not cover it. EI #20 stated the resident received nothing (medication) to treat the psoriasis currently, but staff tried to keep it moisturized and ensure the resident got baths.
During an interview on 06/23/21 at 3:30 PM, EI #20 stated he/she was not aware of the Physician's Order for triamcinolone prescribed on 05/3/21 for treatment of the psoriasis. He/she stated he/she was not sure who ordered it but agreed it was a valid order.
During an interview on 06/24/21 at 11:43 AM, EI #20 stated the order for triamcinolone was signed off by a nurse. He/she verified the order had not been implemented.
During an interview on 06/24/21 at 3:20 PM, the Medical Director (also the resident's physician) stated he/she ordered the triamcinolone cream in May for psoriasis. He/she stated, I would expect the nursing staff to implement the order. I am not sure on the oversight. I talked to the skin nurse and [EI #20] and with the resident's [family member].
During an interview on 06/24/21 at 4:35 PM, EI #2, Director of Nursing (DON) stated he/she had talked with RI #74's family member about the resident's skin and not much had helped (medications). He/she stated the nursing staff should have taken off the order for triamcinolone cream and implemented it, verifying this was not done. EI #2 stated the weekly skin assessments should not document the resident's skin was normal and rather should document the resident's psoriasis.
Review of the paper copy of the Skin Care Guideline policy dated July 2018 revealed the purpose was to provide a system for evaluation of skin to identify risk and identify individual interventions to address risk and a process for care of changes/disruption in skin integrity. The policy indicated weekly review of the resident's skin would be completed by the nurse and documented in the electronic medical record. The resident would be observed by the nurse aide team members daily for changes in skin condition. These changes would be reported to the licensed nurse and documented in the electronic medical record.
2. Review of the admission Record dated 05/23/21, in the EMR under the Profile tab, revealed RI #69 was admitted to the facility on [DATE] with diagnoses including dementia, muscle weakness, and pain.
Review of the Quarterly MDS with an ARD of 05/28/21, in the EMR under the MDS tab, revealed RI #69 re-entered the facility on 05/23/21 following an acute hospital stay. The resident had clear speech and was usually understood by others, and usually understands others. The BIMS test was not conducted. RI #69 required extensive assistance of one staff for toilet use. The resident was always incontinent of bowel and bladder.
Review of the paper Order Summary Report dated 05/31/21, in medical record under Orders, revealed the resident was prescribed oxycodone-acetaminophen (narcotic pain medication) tablet 5-325 mg, give one tablet every four hours as needed ordered on 05/23/21, and Polyethylene Glycol (medication for constipation) 3350 Kit 17 mg daily, ordered on 05/23/21 for other symbolic dysfunction.
Review of the Care Plan initiated on 02/19/20, in the EMR under the Care Plan tab, revealed a focus area of, Alteration in elimination of bowel and bladder AEB (as evidenced by) Bowel and Bladder incontinence, Acute Kidney Failure, assistance needed with transfers, Risk for Constipation and UTI (urinary tract infection). Interventions to address the problem included:
[RI #69] will have a soft formed bowel movement [BM] at least every three days .
Monitor bowel status frequency.
Observe and report changes in ability to toilet or continence status.
Provide extensive assistance x1 (from one person) to toilet.
Review of a paper Hospital's Progress Note dated 04/16/21, in the medical record under the Physician tab, revealed the resident was admitted to the hospital on [DATE] with altered mental status and agitation. The resident had chronic CVAs (strokes); however, there were no acute findings. The CT (computerized tomography) a radiologic imaging indicated the resident had a possible fecal impaction along with concerns of gall bladder changes, possible kidney stones, and chronic cholecystitis. Under the Assessment/Plan heading, RI #69 had a diagnosis of constipation/rectal fecal impaction with administration of an enema and a suppository and the medication Miralax (laxative) was prescribed.
Review of the POC [Point of Care] Response History Report, for bowel elimination, dated 05/23/21 - 06/23/21, in the EMR under the POC tab, revealed the resident had three BMs in the prior 30-day timeframe, occurring on 06/01/21, 06/04/21, and on 06/11/21. There were 10 days when no bowel movement was documented, one day when not applicable was documented. Nothing (no entries for the specified date) was recorded for the remaining 14 days. According to the report, the resident's last BM occurred on 06/11/21.
Review of the paper Lookback Report for 06/01/21 - 06/23/21, printed for the surveyor, also revealed RI #69 had his/her last BM on 06/11/21. The report documented BMs on 06/01/021, 06/04/21 and on 06/11/21.
On 06/21/21 at 3:27 PM, the door was open, and the sound of crying and moaning was heard. RI #69, who was writhing in bed, stated he/she was constipated and asked the surveyor to notify the nurse he/she was very uncomfortable and wanted the nurse to come. The surveyor notified EI#18, licensed practical nurse (LPN) who was at the nurses' desk EI#18 stated the resident's health had declined due to having had open heart surgery a couple months ago. EI#18 stated the resident used to get up and use the commode and could not do that now. EI#18 stated the resident was getting therapy to regain her strength. He/she stated the resident had a history of constipation and it was not unusual for him/her to complain about it.
Review of the Nursing Progress Notes for 06/21/21 in the EMR under the Progress Notes tab showed no documentation of this incident.
During an interview on 06/23/21 at 11:34 AM, EI#23, certified nursing assistant (CNA) stated since the resident had gotten sick, staff had to change her (incontinence brief), dress her and provide total assistance with some ADLs. EI#23 stated RI #69 was walking and self-toileting, he/she got sick, went to the hospital and now he/she wore a brief and could not stand up like she used to. EI#23 stated sometimes the resident knew when he/she needed to go to the bathroom. CNA #3 stated the resident had not complained of constipation the last couple times (he/she assisted her). EI#23 stated the resident had bowel movements every few days.
The bowel policy and/or standing orders for lack of bowel movement/constipation were requested. During an interview on 06/24/21 at 09:40 AM, EI#2 stated there was no bowel protocol or standing orders in place (if a resident did not have a BM) and there was no policy.
During an interview on 06/24/21 at 10:29 AM, EI#20 (charge nurse) stated R#69 had a bowel movement on Monday (06/21/21) according to the CNAs. EI#20 stated, the resident was weak and had difficulty pushing out bowel movements. He/she stated he/she would check with the CNAs to see if the resident had a bowel movement (BM) since 06/21/21. When asked how he/she knew if the resident had bowel movements when the bowel records indicated no bowel movements occurred, he/she stated, The CNAs let us know. I am aware of lack of documentation and that it needs improvement. EI#20 stated he/she was not aware of the hospital documentation showing the recent bowel impaction in April 2021. EI#20 stated he/she thought RI #69 had BMs every few days and had not needed additional medications for constipation (in addition to the Polyethylene Glycol). He/she stated he/she would check with the CNAs to see if RI#69 has had one since Monday (06/21/21).
During a follow up interview on 06/24/21 at 11:51 AM, EI#20 stated the CNAs told him/her RI #69 had BMs on dialysis days following the resident's return from dialysis. The resident had dialysis on Mondays, Wednesdays and Fridays.
During an interview on 06/24/21 at 4:32 PM, EI#2 stated he/she understood a lack of documentation was an issue. EI#2 stated patient care was the routine; however, documentation was not as much the routine. He/she stated, We have seen some improvements. It is nowhere close to where it needs to be.
During an interview on 06/24/21 at 3:18 PM, the Medical Director (also the resident's physician) stated the facility should have complete bowel records. He/she stated, in light of the resident's hospitalization record showing a fecal impaction, the facility should be documenting bowel movements.
Review of a written statement by EI#2 dated 06/24/21 documented in full, Diversicare does not have a specific policy for bowel and bladder.
SERIOUS
(G)
Actual Harm - a resident was hurt due to facility failures
Deficiency F0688
(Tag F0688)
A resident was harmed · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, the facility failed to provide interventions for one of eight residents revi...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, the facility failed to provide interventions for one of eight residents reviewed for range of motion impairment (Resident Identifier (RI) #74). RI #74) had contractures, including to his/her hands with callused areas observed from where his/her fingernails dug into his/her palms in the sample of 34. The contractures developed and/or worsened over the past year. No interventions had been or were currently in place to address the limitations in range of motion.
Findings include:
Review of the undated admission Record, in the electronic medical record (EMR) under the Profile tab revealed RI #74 was admitted to the facility on [DATE] with diagnoses including unspecified dementia, pain, and weakness. The diagnosis of contractures was not documented.
Review of the hospital History and Physical in the resident's chart, dated 06/27/19, revealed RI #74 was admitted to the hospital and was dependent in activities of daily living (ADLs). The resident was admitted to the nursing home following this hospitalization. There was no documentation in the History and Physical of the presence of contractures prior to nursing home admission.
Review of the Significant Change Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 06/26/20, located in the EMR under the MDS tab, revealed the resident did not speak, rarely/never made him/herself understood, rarely/never understood others, and was unable to complete the Brief Interview for Mental Status (BIMS) test. The resident had impaired ROM to both of his/her upper extremities (shoulder, elbow, wrist, hand). The resident was not receiving any physical therapy (PT), or occupational therapy (OT) and he/she was not on a restorative nursing program such as the provision of ROM exercises or splint/brace assistance.
Review of the Quarterly MDS with an ARD of 03/11/21, located in the EMR under the MDS tab, revealed RI #74 now had impairment in ROM on both sides to the upper and lower extremities. The resident received no therapy (PT or OT) and was not on a restorative nursing program such as the provision of ROM exercises or splint/brace assistance.
Review of the Clinical Physician's Orders in the EMR under the Orders tab revealed there were no orders for treatment of the resident's contractures such as application of a splint or device for his/her contracted hands.
Review of the Care Plan revised on 08/26/19, in the EMR under the Care Plan tab, revealed a focus of, Physical functioning deficit related to: Mobility impairment, Self-care impairment, Dementia, Contractures present, Osteoarthritis. There were no interventions on the care plan to address the contractures or to prevent further decline.
During an interview on 06/22/21 at 2:25 PM, RI #74's family member stated the resident did not previously have contractures. He/she stated No one told me about her legs .She can't move her arms, they are crossed . RI #74's family member stated he/she found a sore in RI #74's hand when she opened it and the resident's hand was dirty. He/she stated he/she cleaned the resident's hand and he/she put a wash cloth in the resident's hand but when he/she came to visit the next time it was gone. He/she stated the other hand also had a sore in it. RI #74's family member stated she talked to floor nurse and the RN supervisor about his/her concerns.
Observation on 06/21/21 at 12:22 PM, RI #74 was lying in bed. RI #74's right hand was visible and contracted into a fist. No splint/device was in place in the resident's hand.
Observation on 06/22/21 at 10:08 AM, RI #74 was lying in bed. Both hands were visible and were contracted into fists. No splint or other device was observed in either hand.
Observation on 06/23/21 at 12:57 PM, RI #74 was lying in bed. Both of the resident's arms and hands were observed crossed with his/her contracted hands up near her opposite shoulders. No splint/devices were present in the resident's hands.
On 06/23/21 at 1:25 PM, with Employee Identifier (EI)#20, Registered Nurse (RN) (charge nurse) and RI #74's family member observed RI #74 who was lying in bed. The resident's arms continued to be crossed/contracted with his/her contracted hands near his/her opposite shoulders. No splints/devices were observed in the resident's hands. The resident's legs/knees were also contracted. They were bent in fixed positions. RI #74's hands were partially opened by RI #74's family member. The fingers opened but the resident's hands continued to be in a semi-fist position. There was darkened skin in the palms of the resident's hands. RI #74's family member stated the area in the resident's right hand was raw and the resident's fingernails had been digging in. RI #74's family member stated he/she usually put a towel in the resident's hands.
On 6/24/21 at 9:25AM, EI#12, License Practical Nurse (LPN) observed that RI#74's hands were contracted and rolled wash cloths were located in both of the resident's palms. EI#12 opened the resident's palms to observe the skin. The palms had areas in the fleshy part of palm just below thumbs where the resident had rubbed a callused area, dry but more callused than psoriatic, but not opened.
During an interview on 06/23/21 at 11:38 AM, EI#23, Certified Nursing Assistant (CNA) stated that RI #74 required total care. He/she stated sometimes RI #74 had something in his/her hands and that staff had put wash cloths in his/her hands.
During an interview on 06/23/21 at 1:43 PM, EI#19 stated RI #74 was very contracted. He/she stated there was moisture and the skin was macerated in the resident's hands and he/she had tried to get the wound doctor to see the resident. He/she stated the wound doctor wound not add the resident to his/her rounds because they weren't wounds (area in the hands). He/she stated he/she tried to keep the resident's fingernails trimmed.
During an interview on 06/23/21 at 12:53 PM, EI#20 stated, at one point, something was placed under RI #74's legs to stretch them out, causing him/her to bend more at the hips. EI #20 stated, RI #74 pulls upward. EI #20 stated RI #74 had limitations in hie/her legs before but it had gotten worse. EI #20stated, staff had put things in the resident's hands for the contractures but the resident had not done well and would pull at them and pull them out. EI #20 indicated there was nothing in place currently for the contractures.
During an interview on 06/24/21 at 4:41 PM, EI#2, Director of Nursing (DON) stated he/she thought RI #74's contractures had gotten worse. He/she stated the resident should have a wash cloth in place in his/her hands; however, it was painful for the resident to have something placed in his/her hands and possibly that was the reason staff had not been putting wash cloths in his/her hands.
During an interview on 06/24/21 at 3:20 PM, the Medical Director (also the resident's physician) stated he/she did not know if RI #74's contractures had been addressed. He/she stated the resident's hands were contracted but probably had gotten worse. He/she stated the resident was very demented and indicated the resident's hands would need to be assessed.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Notification of Changes
(Tag F0580)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review and facility policy review, the facility failed to notify the responsible party for one of 34 ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review and facility policy review, the facility failed to notify the responsible party for one of 34 sampled residents (Resident Identifier (RI) #74) of a change in medical treatment and new medical diagnosis. Specifically, an indwelling urinary catheter was inserted without notification of the responsible party.
Findings include:
Review of the facility's policy titled, Notification of Change in Patient/Resident Health Status dated June 2017 revealed the purpose, to ensure all interested parties are informed of the patient's/resident's change in health status so that a treatment plan can be developed which is in the best interest of the patient/resident. The policy revealed the facility would consult the resident's physician, nurse practitioner or physician assistant, and if known notify the patient representative when there was a change in .
(B) Acute illness or a significant change in the resident's physical, mental, or psychosocial status. Notification will be immediate. (i.e., Life threatening conditions are such things as a heart attack or stroke. Clinical complications are such things as development of a new pressure injury, onset or recurrent periods of delirium, recurrent urinary tract infection, or persistent decline in psycho social status)
(C) A need to alter treatment significantly (i.e., a need to discontinue an existing form of treatment due to adverse consequences, or to commence a new form of treatment). Depending on the nursing assessment appropriate notification may be immediate to 48 hours.
Review of the undated admission Record, in the electronic medical record (EMR) under the Profile tab revealed RI #74 was admitted to the facility on [DATE] with diagnoses including unspecified dementia without behavioral disturbance, mixed incontinence, and weakness. RI #74's responsible party and primary emergency contact was RI #74's family member. Review of the undated admission Record, revealed a diagnosis of neuromuscular dysfunction of the bladder was added on 11/18/20.
Review of the Quarterly Minimum Data Set (MDS') with an Assessment Reference Date (ARD) of 03/11/21, in the EMR under the MDS tab, revealed the resident was unable to complete the Brief Interview for Mental Status test. Staff assessed the resident as not having spoken, being rarely/never understood and being rarely/never able to understand. The resident had short and long-term memory impairment and was severely impaired in decision making. RI #74 was totally dependent on one person for toileting assistance. The MDS indicated that an indwelling urinary catheter was in use.
Review of Physician's Order in the EMR under the Orders tab revealed a Foley catheter was initially prescribed on 11/18/20 for diagnoses of neurogenic bladder with incontinence and unstageable sacral wound.
During an interview on 06/22/21 at 02:25, RI #74's family member stated RI #74 was on hospice, indicating the resident had early onset of Alzheimer's disease and was currently very demented and unable to communicate her needs. RI #74's family member stated she was not informed by the facility when the indwelling urinary catheter was inserted and was not informed why the catheter was necessary. RI#74's family member stated that the resident did not have a history of urinary retention. RI #74's family member stated that he/she wanted to be apprised of changes in the resident's care.
Review of the nursing Progress Notes in the EMR under the Progress Notes tab did not include documentation of RI #74's family member being notified of the indwelling urinary catheter placement or of the new diagnoses of neurogenic bladder and neuromuscular dysfunction of the bladder.
During an interview on 06/24/21 at 10:38 AM, Employee Identifier (EI) #20, Registered Nurse (RN) (charge nurse) stated she did not remember notifying RI #74's family member of the catheter placement. EI #20 indicated he/she had reviewed RI #74's medical record and stated, We have no documentation we notified the family of the catheter placement. EI#20, indicated the responsible party should have been notified.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Assessment Accuracy
(Tag F0641)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review, document review and review of the Long-Term Care Resident Assessment Instrument, the facility...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review, document review and review of the Long-Term Care Resident Assessment Instrument, the facility coded the MDS incorrectly for two of 34 residents, Resident Identifier (RI) #75 and 32. Specifically, RI#75 was not coded as receiving hospice services and RI#32 was coded as not being administered an antipsychotic medication.
Findings include:
Review of a document provided by EI#7 dated 06/23/21 revealed, The MDS Department follows the guidelines for Significant Change Assessments and Care plans set forth in the CMS [Center for Medicare and Medicaid Services] RAI [Resident Assessment Instrument] [NAME] (sic).
Review of the Long Term Care Resident Assessment Instrument 3.0 User's Manual, dated October 2019, indicated, The RAI process has multiple regulatory requirements. require that (1) the assessment accurately reflects the resident's status.
1. Review of RI#75's admission Record located under the Profile Tab in the electronic medical record (EMR) indicated the resident was admitted to facility on 01/10/14. Review of the resident's Physician Orders located under the Orders tab of the EMR revealed on 02/24/21 the resident was admitted to hospice with a diagnosis of failure to thrive.
Review of the Significant Change Minimum Data Set (MDS) with an Assessment Review Date (ARD) of 03/04/21 revealed the resident was not coded as receiving hospice services under Section O Special Treatment, Procedure and Programs.
During an interview with the Employee Identifier (EI) #7, MDS Coordinator on 06/24/21 at 3:37 PM, when asked about coding hospice for the March 2021 significant change MDS, he/she stated it should have been coded.
2. Review of RI #32's EMR undated Face Sheet under the face sheet tab revealed RI #32 was admitted to the facility on [DATE] with diagnosis including psychoactive substance dependence, and in 2019 was diagnosed with adjustment disorder with mixed anxiety and depressive mood.
Review of RI #32's quarterly MDS with an ARD of 03/19/21 under the MDS tab revealed RI #32 Brief Interview for Mental Status (BIMS) score was 15 which indicated resident was cognitively intact. There were no behaviors or psychosis documented. The MDS indicated that RI #32 had not received antipsychotic medication during the seven-day assessment period from 03/12/21 through 03/19/21.
Review of RI #32's EMR Clinical Physician Orders dated from 04/20/12 through June 2021 under the orders tab revealed RI #32 was prescribed Abilify (an antipsychotic medication) routine daily starting 10/01/19 and continued to the current active medication orders (June 2021).
Review of RI #32's EMR Medication Administration Record (MAR) dated for the month of March 2021 under the orders tab verified RI #32 had received the antipsychotic medication Abilify daily during the MDS assessment reference period and the entire month of March 2021.
During an interview on 06/24/21 at 3:45 PM, EI#7 confirmed she had incorrectly coded the March quarterly MDS and that she should not have documented a zero under antipsychotic medications received during the look back period. EI#7 stated that RI #32 had received seven days of the antipsychotic medication.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, document review and record review, the facility failed to develop a plan of care for three (Resident Identif...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, document review and record review, the facility failed to develop a plan of care for three (Resident Identifier (RI) #32, RI#74 and RI#75) of 34 residents reviewed for care plans. Specifically, RI #32 was prescribed Abilify, an antipsychotic medication without developing and identifying specific target behavior/s and non-pharmacological interventions for the use of the medication. RI#74 care plan did not reflect interventions for the care of the resident with limited Range of Motion (ROM) and contractures. RI#75's care plan did not address that the resident had an indwelling urinary catheter and the intervention that nursing staff were to provide catheter care per shift and PRN (as needed).
Findings include:
Review of a document provided by EI#7, dated 06/23/21 indicated, The MDS Department follows the guidelines for Significant Change Assessments and Care plans set forth in the CMS [Center for Medicare and Medicaid Services] RAI [Resident Assessment Instrument] Manual (sic).
1. Review of RI #32's electronic medical record (EMR) undated Face Sheet under the face sheet tab revealed RI #32 was admitted to the facility on [DATE] with diagnosis including psychoactive substance dependence, and in 2019 was diagnosed with adjustment disorder with mixed anxiety and depressive mood.
Review of RI #32's EMR annual Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 07/20/20 under the MDS tab revealed RI #32's Brief Interview for Mental Status (BIMS) score of 14 which indicated he/she was cognitively intact. RI #32 received an antipsychotic medication routinely for seven-days during the assessment period and was indicated to have depression listed under psychiatric/mood disorder. The MDS documented RI #32 had no behaviors or psychosis.
Review of RI #32's EMR quarterly MDS with an ARD of 03/19/21 under the MDS tab revealed RI #32's BIMS score was 15 which indicated that he/she was cognitively intact with a psychiatric/mood diagnosis of depression. There were no behaviors or psychosis documented.
Review of RI #32's EMR Clinical Physician Orders dated from 04/20/12 through June 2021 under the orders tab revealed RI #32 was prescribed Abilify (an antipsychotic medication) routine daily starting 10/01/19 and continued to the current active medication orders (June 2021).
Review of RI #32's EMR Care Plan under the care plan tab with various dates revealed RI #32 had a care plan for the use of an antipsychotic medication. The care plan problem and goal were as follows; .02/03/20 Potential for drug related complications associated with the use of psychotropic medications related to antipsychotic medication .the goal RI #32 will be free of psychotropic drug related complications and the target date was for 01/15/21. The care plan interventions were as follows:
.
02/03/20 Observe for side effects and report to physician .,
09/13/19 Psychotropic medication risk/benefit and reduction plan as recommended by physician and pharmacist,
09/13/19 Refer to psychologist/psychiatrist for medication and behavior intervention recommendations .
During an interview on 06/24/21 at 3:45 PM, EI#7, MDS Coordinator confirmed RI #32's care plan should have been developed to reflect target behavior/s and non-pharmacological interventions related to the use of psychotropic medications specifically, an antipsychotic medication.
2. Review of the undated admission Record, in the EMR under the Profile tab revealed RI #74 was admitted to the facility on [DATE].
Review of the Clinical Physician's Orders in the EMR under the Orders tab revealed RI #74 was admitted to hospice on 05/19/20.
Review of the Significant Change MDS with an ARD of 06/26/20, located in the EMR under the MDS tab, revealed the resident had impaired ROM to both of his/her upper extremities (shoulder, elbow, wrist, hand). The resident was not receiving any physical therapy (PT), or occupational therapy (OT) and he/she was not on a restorative nursing program for provision of ROM exercises or splint/brace assistance.
Review of the Quarterly MDS, with an ARD of 03/11/21, located in the EMR under the MDS tab, revealed RI #74 now had impairment in ROM on both sides to the upper and lower extremities. The resident received no therapy (PT or OT) and was not on a restorative nursing program such as the provision of ROM exercises or splint/brace assistance.
Review of the Care Plan revised on 08/26/19, in the EMR under the Care Plan tab, revealed a focus of, Physical functioning deficit related to: Mobility impairment, Self-care impairment, Dementia, Contractures present, Osteoarthritis. Although the contractures were identified on the care plan, the location of the contractures was not identified and there were no interventions to address the contractures or to prevent further decline.
During an interview on 06/24/21 at 4:01 PM, EI#7 stated there should be interventions care planned for RI#74's limited ROM and contractures.
3. Review of RI#75's Physicians Orders found in the EMR under the Orders Tab indicated on 11/12/20, the Medical Director ordered, Insert straight catheter every 8 hours to monitor for urinary retention. On 01/02/21, the Physician Order, indicated, foley catheter care every shift and PRN.
Review of the quarterly MDS with an ARD of 02/04/21 and 06/04/21 indicated that RI#75 had an indwelling urinary catheter.
Review of RI#75's care plan, found under the Care Plan tab of the EMR, indicated on 11/06/20 a care plan Focus for Alteration in elimination of bowel and bladder intermittent catheter for urinary retention was initiated. The care plan was not revised when the indwelling foley catheter was inserted.
Interview with Employee Identifier (EI) #7 on 06/24/21 03:37 PM, stated the resident received an order for an indwelling urinary catheter in January. When asked should the care plan have been updated, he/she stated, Absolutely it should have been updated in January.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
ADL Care
(Tag F0677)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, document review and record review, the facility failed to ensure two of 34 sampled residents requiring assis...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, document review and record review, the facility failed to ensure two of 34 sampled residents requiring assistance with activities of daily living (ADLs) (Resident Identifier (RI) #93 and RI#32) and one supplemental resident who wished to remain anonymous received their scheduled baths.
Findings include:
1. Review of the undated admission Record located in the electronic medical record (EMR) under the Profile section, revealed RI #93 was admitted to the facility on [DATE] with diagnoses including multifocal leukoencephalopathy (progressive viral disease of the central nervous system), cerebral infarction (stroke), hemiplegia (complete loss of strength or paralysis on one side of the body), muscle weakness, and lack of coordination.
Review of the Care plan dated 04/06/18 in the EMR under the Care Plan tab revealed the focus area of Physical functioning deficit related to: Mobility impairment, Self-care impairment, Progressive Multifocal Leukoencephalopathy, Epilepsy, Muscle weakness, Lack of Coordination, and Paralysis of the lower extremities. The goal was for the resident to maintain his current level of functioning. Approaches included providing extensive assistance with dressing and hygiene, encouraging choices with care, and reporting changes in physical functioning abilities.
Review of the Quarterly Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 05/14/21, located in the EMR under the MDS tab, revealed RI #93 had a Brief Interview for Mental Status (BIMS) score of 15 out of 15 indicating the resident was cognitively intact. The resident had no mood or behavioral indicators. RI #93 required extensive assistance of one staff for personal hygiene and required physical help from one person for bathing.
During an interview on 06/21/21 at 1:22 PM, RI #93 stated that he/she needed assistance with activities of daily living due to a stroke that resulted in weakness to his/her left side. RI #93 stated he/she did not receive baths/showers in accordance with his/her bath/shower schedule. He/she stated he/she preferred three showers a week per the schedule, but might get two. He/she stated if the facility was short of staff, he/she did not get his/her baths/showers.
Review of the undated Shower Schedule for Each Unit revealed all residents were to be bathed three times a week either on Monday, Wednesday and Friday or on Tuesday, Thursday and Saturday. Showers were based on the resident's room number and bed assignment. Half of the residents were to be bathed on the 7:00 AM - 3:00 PM shift and half on the 3:00 PM - 11:00 PM shift
Review of the Follow Up Question Report dated 04/01/21 - 05/31/21 revealed RI #93 received a total of three bed baths and that he/she received no showers or tub baths during this two-month period. Review of the Follow Up Question Report dated 06/01/21 - 06/24/21 revealed RI #93 received a total of seven bed baths and that he/she did not receive any showers or tub baths during this 24-day period.
During an interview on 06/23/21 at 11:44 AM, Employee Identifier (EI)#23, Certified Nurse Assistant (CNA) stated RI #93 had no cognitive impairment. EI#23 stated there were no assigned bath aides and the CNAs gave the residents baths as part of their assignments. EI#23 stated residents were scheduled for three baths/showers per week according to their room numbers, however, when staffing was short, residents might not get their baths. EI#23, stated that the CNAs documented in the kiosk when baths were given.
During an interview on 06/24/21 at 4:26 PM, EI#2, Director of Nursing (DON) confirmed that the bath/shower records did not illustrate the resident had received any showers from 04/01/21 - 06/23/21. EI#2 stated, The records are not complete but that is all we have.
2. During an interview on 06/21/21 at 3:38 PM, a resident who requested to remain anonymous stated he/she did not always get her baths, especially on evening shift when the facility was short staffed. This resident resided on the 4th floor.
3. Review of RI #32's EMR undated Face Sheet under the face sheet tab revealed RI #32 was admitted to the facility on [DATE].
Review of RI #32's EMR annual MDS with an ARD of 07/20/20 under the MDS tab revealed RI #32's BIMS score was a 14 which indicated he/she was cognitively intact. It was documented bathing was a very important daily preference to RI #32 and he/she required supervision to limited assist of one staff member for bathing and dressing.
Review of RI #32's EMR quarterly MDS with an ARD of 03/19/21 under the MDS tab revealed RI #32's BIMS score was 15 which indicated he/she was cognitively intact with a psychiatric/mood diagnosis of depression. It was documented RI #32 required partial to limited staff assist with daily bathing and dressing.
Review of RI #32's EMR Care Plan under the care plan tab with various dates revealed RI #32 had a care plan problem developed for physical functioning deficit dated 09/13/19 with a goal dated 07/17/21 to improve current level of functioning. The interventions were as follows:
.Personal hygiene extensive assistance .
Review of RI #32's Follow Up Question Report for ADL Bathing documentation provided by the facility dated from April 2021 to June 2021 revealed RI #32 had received no showers and three full bed baths provided. In the month of May 2021 RI #32 had received no showers, one partial, and one full bed bath provided. In the month of June 2021 RI #32 had received one shower, two partial, and four full bed baths provided.
During an interview on 06/21/21 at 11:45 AM, RI #32 stated he/she had a complaint that he/she only received showers once weekly if that much and, on most weeks, it was due to short staffing. RI #32 stated his/her preference was evening showers and the evening shift was the shortest staffed.
Review of the Shower Schedule undated and provided by the facility (Not located in the EMR) revealed RI #32's shower was scheduled for the evening shift.
Further review of RI #32's Follow Up Question Report for ADL Bathing documentation dated from April 2021 through June 2021 revealed no showers or baths completed were provided on the evening shift.
During an interview on 06/24/21 at 12:40 PM, EI#20-,Registered Nurse (RN), who was designated the Unit Manager of RI #32's wing, confirmed RI #32 was accurate, he/she had not been receiving showers as scheduled. EI#20 stated RI #32 was independent with staff set up and RI #32 could wash his/her upper body himself/herself with only supervision. EI#20 confirmed the facility considered a bed bath the same as receiving a shower. EI#20 stated according to his/her understanding RI #32 preferred a shower but would accept a bed bath.
During an interview on 06/24/21 at 5:05 PM, RI #32 stated that he/she would agree that most of the missed showers were due to agency staff not doing the showers versus them just not getting done in general. RI #32 stated he/she had not in the past informed the Unit Manager when he/she had not received his/her shower. He/she stated he/she did not mind getting a bed bath but would like to have a shower every now and then.
A shower/bath policy was requested on 06/24/21, however, a policy was not provided as of the facility exit on this date.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0679
(Tag F0679)
Could have caused harm · This affected 1 resident
Based on record review, document review and interview, the facility failed to provide an ongoing program to support residents in their choice of activities designed to meet the interests of and suppor...
Read full inspector narrative →
Based on record review, document review and interview, the facility failed to provide an ongoing program to support residents in their choice of activities designed to meet the interests of and support the well-being of each resident for three of 34 residents, Resident Identifier (RI) #'s 85, 39 and 53, reviewed for activities.
Findings include:
During an interview on 06/21/21 at 10:30 AM, RI#85 stated that there have not been any activities offered since the majority of the Coronavirus Disease 2019 (COVID-19) restrictions have been lifted. RI #85 stated he/she missed the church services that used to occur on site and being taken on outings.
During an interview on 06/21/21 at 10:45 AM, RI #39 stated that he/she would like the opportunity to participate in activities since COVID-19 was not such an issue at this time.
During an interview on 06/21/21 2:00 PM, RI #53 stated that he/she missed the morning social (10:00 AM-11:00 AM) that would occur in the main dining room. RI# 53 stated that residents could get together, drink coffee and have a snack. RI #53 stated that the residents have missed playing BINGO and winning prizes. RI #53 stated that during COVID-19 staff would come by with a cart and offered residents various activities they could do in their rooms, but even that activity has not been occurring.
During an interview on 06/23/21 at 9:35 AM with Employee Identifier (EI) #4, the Activities Director (AD) explained that prior to COVID-19 and more recently, the facility did provide holiday celebrations for the residents.
During an interview on 06/23/21 at 10:00 AM with EI#2, the Director of Nursing (DON) stated that throughout COVID-19 nursing staff did conduct some activities for the residents.
EI#1, Administrator provided a document titled, Diversicare of Bessemer Activities Program March 2020 through May 2021 which indicated, Activities for the Center have been composed of those activities that could be accomplished with social distancing, frequent hand hygiene and appropriate personal protective equipment in place .Activity books and games were placed in rooms for personal use. Music and entertainment that could be conducted from the hallway for all to enjoy were implemented at varied intervals .Nurses and Certified Nursing Assistants worked to present special moments to the residents on all floors. Theme party or a Seasonal celebration provided additional time for residents to enjoy laughter, songs .
EI #1 provided a written statement from EI#25, Social Services Director, dated 06/23/21 which indicated, .Checking in with residents to ensure that they were coping as well as could be expected. Assisting the residents with telephones calls to family using social worker's cell phone and/or facility's cordless phones to talk and/or face time. If requested (although always suggested) arrange weekly zoom calls .Social worker would also offer and provide residents with the MP3s to listen to music of their choice. Social worker also had a supply of activity booklets related to resident rights .which was passed out .Staff would make religious service available to residents through their TVs, radios, or the facility's .Family would call facility to set a time that they could come and see their loved ones (through window visits) .
EI #1 provided a written statement by EI#26, Director of Care Coordination, dated 06/23/21 which indicated, Zoom calls were held weekly on Thursdays and as requested any other day during the week by residents or their family members . I oversaw the Zoom calls schedule and assigned them to be set up for the residents and conducted by the speech therapists .There would be approximately 10-12 Zoom calls on the scheduled Thursday.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0565
(Tag F0565)
Could have caused harm · This affected multiple residents
Based on interview and document review, the facility failed to support the residents' right to participate in a resident group by not restarting the resident council meetings post Coronavirus Disease ...
Read full inspector narrative →
Based on interview and document review, the facility failed to support the residents' right to participate in a resident group by not restarting the resident council meetings post Coronavirus Disease 2019 (COVID-19). This deficient practice affected four residents in the sample of 34 (Resident Identifier (RI) #'s 85, 2, 39 and 53).
Findings include:
During an interview on 06/21/21 at 10:30 AM, Resident Identifier (RI) #85 stated he/she did attend Resident Council (RC) meetings prior to the COVID-19 pandemic, but there have not been any meetings held since they were discontinued due to the pandemic restrictions.
During an interview on 06/21/21 at 10:40 AM, RI #2 stated he/she did attend RC meetings prior to the COVID-19 pandemic, but there have not been any meetings held since they were discontinued due to the pandemic.
During an interview on 06/21/21 at 11:00 AM, RI #39 stated he/she did attend RC meetings prior to the COVID-19 pandemic, but the RC meetings have not been restarted post pandemic.
During an interview on 06/21/21 at 2:30 PM, RI #53 stated he/she did attend RC meetings prior to the COVID-19 pandemic, but there have not been any meetings held since they were discontinued during the pandemic. RI #53 revealed he/she was the RC President.
During an interview on 06/23/21 at 9:25 AM, Employee Identifier (EI) #4, the Activities Director stated that RC meetings have not been occurring to my knowledge.
During an interview on 06/23/21 at 10:00 AM, EI #2, Director of Nursing (DON), E stated RC meetings were being held prior to COVID-19.
Review of the RC Binder revealed the last recorded RC meeting was held March of 2020 with 10 residents in attendance.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Drug Regimen Review
(Tag F0756)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review, document review, facility assessment, policy review and review of Centers for Medicare and Me...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, record review, document review, facility assessment, policy review and review of Centers for Medicare and Medicaid memo, the facility failed to ensure pharmacy services thoroughly reviewed the resident medication regimens to identify irregularities related to the use of psychotropic medications, and residents who were prescribed psychotropic medications received gradual dose reductions (GDR) or had a physician documented clinical rationale for the continued use of the psychotropic medication for four (Resident Identifier (RI) #32, RI#76, RI#75 and RI#18) of five residents reviewed for unnecessary psychotropic medication.
Findings include:
1. Review of RI #32's electronic medical record (EMR) undated Face Sheet under the face sheet tab revealed RI #32 was admitted to the facility on [DATE].
Review of RI #32's EMR annual Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 07/20/20 under the MDS tab revealed RI #32's Brief Interview for Mental Status (BIMS) score was a 14 which indicated he/she was cognitively intact. RI #32 received an antipsychotic, antidepressant, and antianxiety medication routinely for seven-days during the assessment period and was indicated to have depression listed under psychiatric/mood disorder. It was documented RI #32 had no behaviors or psychosis.
Review of RI #32's EMR quarterly MDS with an ARD of 03/19/21 under the MDS tab revealed RI #32's BIMS score was 15 which indicated that he/she was cognitively intact with a psychiatric/mood diagnosis of depression. It was documented RI #32 received an antidepressant and antianxiety medication routinely for seven-days during the assessment period and was indicated to have depression under psychiatric/mood disorder. There were no behaviors or psychosis documented. There was no documentation RI #32 received an antipsychotic medication.
Review of RI #32's EMR Medication Administration Record (MAR) dated for the month of March 2021 under the orders tab verified RI #32 had received the antipsychotic medication Abilify daily during the MDS ARD of 03/19/21 and for the entire month of March 2021.
Review of RI #32's EMR Clinical Physician Orders dated from 04/20/12 through June 2021 under the orders tab revealed RI #32 was prescribed Abilify (an antipsychotic medication) routine daily starting 10/01/19 and continued to the current active medication orders (June 2021).
Review of RI #32's EMR Care Plan under the care plan tab with various dates revealed RI #32 had a care plan for the use of an antidepressant, antianxiety, and antipsychotic medication. The care plan problem and goal were as follows; .02/03/20 Potential for drug related complications associated with the use of psychotropic medications .the goal RI #32 will be free of psychotropic drug related complications and the target date was for 01/15/21. The care plan interventions were as follows:
.08/02/19 Monthly pharmacy review of medication regimen,
09/13/19 Psychotropic medication risk/benefit and reduction plan as recommended by physician and pharmacist .
Review of RI #32's handwritten Physician's Orders located in the hard copy chart dated 06/03/21 revealed there was a physician order to discontinue Abilify 2 milligrams (mg) and start Abilify 5 mg every day (QD). There was no specification to which 2 mg Abilify order was to be discontinued. RI #32 had been prescribed Abilify 2 mg by mouth (PO) every night at hour of sleep (QHS) on 02/17/21 in addition to a prior order of Abilify 2 mg PO QD ordered on 12/04/20. Only one of the Abilify 2 mg orders was discontinued on 06/03/21 leaving one Abilify 2 mg order and the new Abilify 5 mg order for a total of 7 mgs of Abilify prescribed daily. This irregularity was not identified through pharmacy review or by the facility.
Review of the facility's monthly Gradual Dose Reduction Tracking Report provided by the facility and completed by the pharmacy dated from January 2021 through May 2021 revealed there was no tracking report provided for the month of March 2021. The report detailed the following information:
In January 2021 RI #32 was prescribed a routine antipsychotic medication for mood disorder starting on 10/01/19 with the next review for a GDR on 04/01/21. There was no pharmacy GDR consultation report provided for this medication review.
In February 2021 RI #32 was prescribed a routine antipsychotic medication for mood disorder starting on 10/01/19 with the next review for a GDR on 04/01/21. There was no pharmacy GDR consultation report provided for this medication review.
In April 2021 RI #32 was prescribed a routine antipsychotic medication for mood disorder starting on 10/01/19 with the next review for a GDR on 04/23/21. There was no pharmacy GDR consultation report provided for this medication review.
In May 2021 RI #32 was prescribed a routine antidepressant medication for depression on 10/01/19, antipsychotic medication for mood disorder on 10/01/19, and an anxiolytic medication for anxiety on 12/04/20. The antidepressant next review for GDR was on 03/31/22, the antipsychotic next review for GDR was on 10/29/21, and the antianxiety next review for GDR was on 01/28/22. There were no pharmacy consultation reports provided for these medication reviews.
Review of RI #32's pharmacy Consultation Report for GDR recommendations dated October 22, 2020, through October 25, 2020, revealed documentation that the pharmacy reviewed the following psychotropic medications: Abilify 1 mg QD, Elavil 25 mg QHS, Cymbalta 30 mg twice daily (BID), and Ambien 5 mg QHS. It was documented the physician declined the GDR without an appropriate clinical rationale to continue the prescribed medications. There were no GDR pharmacy consultation report recommendations for the dates of January 2021 through May 2021 to correlate with the dates of the monthly Gradual Dose Reduction Tracking Report.
Review of RI #32's physician visit progress note with no title dated 01/13/21, located in the MISC section of the EMR revealed RI #32 was seen by the physician for a readmission from the hospital and annual review. The physician documented reviewing the antianxiety, antidepressant and antipsychotic medications and the plan stated the medication to be continued, consider taper or adjustment if patient tolerates and psych consult as needed. The goal documented was the .member's depression will improve by goal target date 01/13/22 . There was no documentation of an attempted gradual dose reduction, no clinical rationale for continuing the psychotropic medications and no assessment of the resident's identified target behaviors related to the prescribed medications.
Review of RI #32's physician visit progress notes with no title dated 02/15/21, 03/12/21, 03/23/21, 04/26/21, 05/20/21, 05/24/21, and 06/07/21, revealed there was no documentation of attempted gradual dose reduction for the prescribed psychotropic medications, no clinical rationale for continuing the psychotropic medications and no assessment of the resident's identified target behaviors related to the prescribed medications.
During an interview on 06/24/21 at 2:47 PM, the Medical Director (MD) confirmed RI #32's Abilify medication was generally used for specific type of diagnoses such as schizophrenia and bipolar disorder and stated RI #32 did not have those diagnoses. The MD stated due to the COVID pandemic the main concern was making sure the residents were doing well emotionally and he/she had not wanted to make any unnecessary medication changes and the goal was to not be too aggressive. In regard to RI #32's prescribed medication Abilify and the discrepancy with the written Abilify order in June 2021, the MD stated the 4 mg dose had to be ordered for once a day and did not come in a 4 mg tablet, so he/she had to order the 5 mg tablet daily. The MD stated he/she was not aware the facility had not discontinued both of the prior 2 mg daily orders. The MD confirmed the intention was not for the resident to be prescribed a total of 7 mg daily and stated that was facility and pharmacy error and confirmed the order should have been clarified. The MD stated RI #32 was originally placed on psychotropic medications by another physician and that physician was a psychiatrist from the community prior to RI #32's admission to the facility. The MD stated the community physician knew RI #32 well and had treated him/her for psychiatric depression. The MD stated it was his/her opinion that was why RI #32 was placed on the Abilify antipsychotic medication in the first place.
2. Review of RI #76's undated Face Sheet in the EMR revealed the resident was admitted on [DATE] with diagnoses including: cellulitis of right below the knee amputation/stump, muscle weakness, unsteady gait and falls.
Review of a scanned physicians progress note found in the MISC tab of the EMR and dated 04/05/21 revealed the MD was RI#76's attending physician. Review of RI#76's gero-psychiatric evaluation dated 02/20/21 indicated RI#76 reported no history of mental health treatment prior to this assessment. The psychiatrist added Trazadone (an antidepressant/sedative medication) to aid in sleep and recommended supportive treatment .follow up 1-2 months . There were no other psychiatric notes located in the medical record review.
Review of RI#76's Physician Orders under the Orders tab, in the EMR for the months of January 2021 through June 2021 revealed the resident was prescribed the following psychotropic medications:
Prozac (anti-anxiety medication) 20mg daily for depression (not included in diagnoses list);
Seroquel (anti-psychotic medication) 150mg daily for behavioral disturbances and acute agitation. There was no appropriate psychiatric diagnosis for RI#76's use of an antipsychotic medications:
Trazadone (antidepressant medication) 150mg at bedtime for depression/sleep;
-Trileptal (anti-seizure medication) 600mg twice daily for mood. There was no indication in the medical record review that RI #76 had seizures; and
Zyprexa (antipsychotic medication) 10mg twice daily for agitation. There was no psychiatric diagnosis for RI#76's use of an antipsychotic medication.
Review of the consultant pharmacy monthly reviews for RI#76 titled, Gradual Dose Reduction Tracking Report from the resident's admission in January 2021 through the current survey in June 2021 revealed the following:
February 26, 21 - revealed the pharmacy requested a diagnosis (required for antipsychotics) to support the use of the Seroquel.
March 30, 21 - again, the pharmacy requested a supporting psychiatric diagnosis.
April 26, 21 - the request for a supporting diagnosis had not been answered.
May 27, 21 - the physician added an additional antipsychotic (Zyprexa). There continued to be no supporting psychiatric diagnosis to support the use of antipsychotics. Additionally, on this report the pharmacist noted the MD had also added Prozac on 05/20/21. Prozac is a Selective Serotonin Reuptake Inhibitor/SSRI a psychoactive medication used to treat depression, obsessive-compulsive disorder, bulimia, and panic disorder. RI#76 did not have a diagnosis to support the use of Prozac. The MD also added Trileptal on 05/20/21 for mood. Trileptal is an anticonvulsant medication but has been used off label to modify mood/behaviors. RI#76 had no diagnoses of mood disorders or of seizures/convulsions.
A phone interview on 06/24/21 at 12:00 PM, with the Consultant Pharmacist revealed she did not believe there were specific pharmacy policies for performing GDRs. The Consultant Pharmacist stated, .we try to go slow and stay low with respect to psychoactive medications. When asked if she followed up with the physician when the pharmacy recommendations went unanswered, the Consultant Pharmacist stated, No.
3. Review of RI# 75's admission Record located in the EMR indicated the resident was admitted to facility on 01/10/14 with a diagnosis that included but not limited to Alzheimer, dementia without behavioral disturbance, and anxiety disorder.
Review of RI#75's Physician Orders located under the Orders Tab of the EMR for May 2021 and June 2021 revealed the resident was prescribed Seroquel.
Further review of the Physician Order, found under the Orders Tab of the EMR, dated 11/18/20, documented, Seroquel tablet 100 mg. Give one tablet at bedtime related to unspecified dementia without behavioral disturbance. On 04/13/21, RI#75 was ordered Seroquel tablet 100mg. Give one 50 mg every morning and at bedtime related to unspecified Dementia without behavioral disturbance.
During an interview with the Consultant Pharmacist on 06/24/21 at 12:09 PM, the Pharmacist stated that on April 26, 2021, she completed a recommendation to clarify the diagnosis of dementia without behavioral disturbance and to change the diagnosis to dementia with behavioral disturbances if he/she was having behaviors. When asked if he/she thought the diagnosis was appropriate indication for use [for the antipsychotic], EI#24 stated, I think so if the resident is on an antipsychotic for dementia with behavioral disturbance.
Review of the Gradual Dose Reduction Tracking Report, provided by the facility revealed RI#75 was reviewed for use of antipsychotic medication on 12/17/21, 01/26/21 and 02/26/21. Further review of the Consultation Report completed by the Consultant Pharmacist and provided by the facility, indicated there was a recommendation to discontinue the as needed order for the medication Seroquel due to antipsychotic medications can only be limited to 14 days. This was the only Consultation Report the facility was able to provide.
4. Review of RI #18's undated Face Sheet in the EMR revealed RI #18 was admitted on [DATE] with diagnoses of adjustment disorder with depressed mood, unspecified dementia with behavioral disturbance, anxiety disorder due to known physiological condition, traumatic brain injury.
Review of RI #18's admission MDS with an ARD dated 03/09/21 revealed RI #18 was moderately cognitively impaired with no behaviors. RI #18 was independent with activities of daily living. RI #18 received an anti-psychotic medication during the assessment period.
Review of RI #18's EMR annual MDS with an ARD of 03/09/21 under the MDS tab revealed RI #18's BIMS score was a 11 which indicated he/she was moderately cognitively impaired. RI #18 received an antipsychotic, antidepressant, and antianxiety medication routinely for seven-days during the assessment period. It was documented RI #18 had no behaviors or psychosis.
Review of RI #18's EMR Order Summary Report dated 06/24/21 under the orders tab revealed RI #18 was prescribed Seroquel routine daily starting 03/19/20 and continued to the current active medication orders (June 2021).
Review of RI #18's EMR Care Plan under the care plan tab with the target date of 06/22/21 revealed RI #18 had a care plan for the use of an antidepressant, antianxiety, and antipsychotic medication. The care plan problem and goal were as follows; .revision date 04/26/21 Potential for drug related complications associated with the use of psychotropic medications .the goal RI #18 will be free of psychotropic drug related complications and the target date was for 09/20/21. The care plan interventions were as follows: .05/07/17 Monthly pharmacy review of medication regimen, 05/07/17 Medication risk/benefit and reduction plan as recommended by physician and pharmacist .
During an interview on 06/24/21 at 12:05 PM, the Consultant Pharmacist stated that EI#2, Director of Nursing (DON) should have the paper copies of the gradual dose reduction request she made for RI #18 for the dates of 08/11/20, 12/16/20 and 04/26/21.
During an interview on 06/24/21 at 3:55 PM, EI #2 stated she could not locate the GDR requests made by the Consultant Pharmacist for RI #18 for the dates of 08/11/20, 12/16/20 and 04/26/21.
Review of RI #18's physician's visit progress notes with no title dated 02/22/21 and 03/22/21 revealed there was no documentation of attempted gradual dose reduction for the prescribed psychotropic medications, no clinical rationale for continuing the psychotropic medications and no assessment of the resident's identified target behaviors related to the prescribed medications.
Review of the Facility Assessment Tool dated/reviewed on 06/04/21 revealed under the Mental Health and Behavior section, Manage the medical condition and medication-related issues causing psychiatric symptoms and behaviors, identify and implement interventions to help support individuals with these issues . Under the Medications section of the assessment indicated, .Assessment/management of polypharmacy is important. Gradual dose reduction is done on antipsychotic medications, antianxiety medications, antidepressant medications, anxiolytics/antianxiety and hypnotics.
Review of Centers for Medicare and Medicaid S&Q Memo Ref 13-35-NH dated May 24, 2013 revealed: . When antipsychotic medications are used without an adequate rationale, or for the purpose of limiting or controlling behavior of an unidentified cause, there is little chance that they will be effective. In addition, they commonly cause complications such as movement disorders, falls, hip fractures, cerebrovascular adverse events (cerebrovascular accidents and transient ischemic events) and increased risk of death .
Review of the undated facility's policy titled, Antipsychotic Reduction Guide indicated that the facility would establish a quality committee to monitor all antipsychotic medications at least monthly and consider tapering or discontinuing the use of antipsychotic medication in the residents that do not exhibit behaviors.
The facility provided a letter dated 06/23/21 which indicated the facility did not have a psychotropic medication policy.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Medication Errors
(Tag F0758)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, staff interviews, review of the facility's assessment, review of the manufacturer's guidelines for medic...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, staff interviews, review of the facility's assessment, review of the manufacturer's guidelines for medication use, review of Centers for Medicare and Medicaid Services memo and review of the facility's policies and procedures, the facility failed to ensure that four of five residents (Resident Identifier (RI) #18, RI#32, RI#75, and RI#76) were free from unnecessary psychotropic medications. Specifically, an antipsychotic and psychoactive medications were used by the facility without an attempted gradual dose reduction (GDR), proper medical rationale, proper indication for use, and the lack of /or behavior and side effect monitoring. Additionally, residents received PRN (as needed) anti-anxiety medication for more than 14 days without proper medical rationale and/or indication for use.
Findings include:
Review of Centers for Medicare and Medicaid S&Q Memo Ref 13-35-NH dated May 24, 2013 revealed: . The problematic use of medications, such as antipsychotics, is part of a larger, growing concern. This concern is that nursing homes and other settings (i.e., hospitals, ambulatory care) may use medications as a quick fix for behavioral symptoms or as a substitute for a holistic approach that involves a thorough assessment of underlying causes of behaviors and individualized, person-centered interventions . When antipsychotic medications are used without an adequate rationale, or for the purpose of limiting or controlling behavior of an unidentified cause, there is little chance that they will be effective. In addition, they commonly cause complications such as movement disorders, falls, hip fractures, cerebrovascular adverse events (cerebrovascular accidents and transient ischemic events) and increased risk of death .
Review of the facility's Facility Assessment Tool dated/reviewed on 06/04/21 revealed under the Mental Health and Behavior section, Manage the medical condition and medication-related issues causing psychiatric symptoms and behaviors, identify and implement interventions to help support individuals with these issues .Under the Medications section of the assessment indicated, .Assessment/management of polypharmacy is important. Gradual dose reduction is done on antipsychotic medications, antianxiety medications, antidepressant medications, anxiolytics/antianxiety and hypnotics .
1. Review of RI #32's electronic medical record (EMR) undated Face Sheet under the face sheet tab revealed RI #32 was admitted to the facility on [DATE].
Review of RI #32's EMR annual Minimum Data Set (MDS) with an Assessment Reference Date (ARD) of 07/20/20 under the MDS tab revealed RI #32's Brief Interview for Mental Status (BIMS) score was a 14 which indicated he/she was cognitively intact. RI #32 received an antipsychotic, antidepressant, and antianxiety medication routinely for seven-days during the assessment period and was indicated to have depression listed under psychiatric/mood disorder. It was documented RI #32 had no behaviors or psychosis.
Review of RI #32's EMR quarterly MDS with an ARD of 03/19/21 under the MDS tab revealed RI #32's BIMS score was 15 which indicated he/she was cognitively intact with a psychiatric/mood diagnosis of depression. It was documented RI #32 received an antidepressant and antianxiety medication routinely for seven-days during the assessment period and was indicated to have depression under psychiatric/mood disorder. There were no behaviors or psychosis documented. There was no documentation RI #32 received an antipsychotic medication.
Review of RI #32's EMR Medication Administration Record (MAR) dated for the month of March 2021 under the orders tab verified RI #32 had received the antipsychotic medication Abilify daily during the MDS ARD of 03/19/21 and for the entire month of March 2021.
Review of RI #32's EMR Clinical Physician Orders dated from 04/20/12 through June 2021 under the orders tab revealed RI #32 was prescribed Abilify (an antipsychotic medication) routine daily starting 10/01/19 and continued to the current active medication orders (June 2021).
Review of RI #32's handwritten Physician's Orders located in the hard copy chart dated 06/03/21 revealed there was a physician order to discontinue Abilify 2 milligrams (mg) and start Abilify 5 mg every day (QD). There was no specification to which 2 mg Abilify order was to be discontinued. RI #32 had been prescribed Abilify 2 mg by mouth (PO) every night at hour of sleep (QHS) on 02/17/21 in addition to a prior order of Abilify 2 mg PO QD ordered on 12/04/20. Only one of the Abilify 2 mg orders was discontinued on 06/03/21 leaving one Abilify 2 mg order and the new Abilify 5 mg order for a total of 7 mgs of Abilify prescribed daily. This irregularity was not identified through pharmacy review or by the facility until the re-certification survey from 06/21/21 through 06/24/21.
Review of the facility's monthly Gradual Dose Reduction Tracking Report provided by the facility and completed by the pharmacy dated from January 2021 through May 2021 revealed there was no tracking report provided for the month of March 2021. The report detailed the following information:
In January 2021, RI #32 was prescribed a routine antipsychotic medication for mood disorder starting on 10/01/19 with the next review for a GDR on 04/01/21. There was no pharmacy GDR consultation report provided for this medication review.
In February 2021, RI #32 was prescribed a routine antipsychotic medication for mood disorder starting on 10/01/19 with the next review for a GDR on 04/01/21. There was no pharmacy GDR consultation report provided for this medication review.
In April 2021, RI #32 was prescribed a routine antipsychotic medication for mood disorder starting on 10/01/19 with the next review for a GDR on 04/23/21. There was no pharmacy GDR consultation report provided for this medication review.
In May 2021, RI #32 was prescribed a routine antidepressant medication for depression on 10/01/19, antipsychotic medication for mood disorder on 10/01/19, and an anxiolytic medication for anxiety on 12/04/20. The antidepressant next review for GDR was on 03/31/22, the antipsychotic next review for GDR was on 10/29/21, and the antianxiety next review for GDR was on 01/28/22. There were no pharmacy consultation reports provided for these medication reviews.
Review of RI #32's pharmacy Consultation Report for GDR recommendations dated October 22, 2020, through October 25, 2020, revealed documentation that the pharmacy reviewed the following psychotropic medications: Abilify 1 mg QD, Elavil 25 mg QHS, Cymbalta 30 mg twice daily (BID), and Ambien 5 mg QHS. It was documented the physician declined the GDR without an appropriate clinical rationale to continue the prescribed medications. There were no GDR pharmacy consultation report recommendations for the dates of January 2021 through May 2021 to correlate with the dates of the monthly Gradual Dose Reduction Tracking Report.
Review of RI #32's EMR General and Weekly Nurses Notes located under the Progress Notes tab dated from 01/04/21 through 06/04/21 revealed there was no documentation of RI #32's behaviors related to the routine use of multiple psychotropic medications.
Review of RI #32's physician visit progress note with no title dated 01/13/21, located in the MISC (miscellaneous) tab of the EMR revealed RI #32 was seen by the physician for a readmission from the hospital and annual review. The physician documented he was reviewing the antianxiety, antidepressant and antipsychotic medications and the plan stated the medication to be continued, consider taper or adjustment if patient tolerates and psych consult as needed. The goal documented was the .member's depression will improve by goal target date 01/13/22 . There was no documentation of an attempted gradual dose reduction, no clinical rationale for continuing the psychotropic medications and no assessment of the resident's identified target behaviors related to the prescribed medications.
Review of RI #32's physician visit progress notes with no title dated 02/15/21, 03/12/21, 03/23/21, 04/26/21, 05/20/21, 05/24/21, and 06/07/21, revealed there was no documentation of attempted gradual dose reduction for the prescribed psychotropic medications, no clinical rationale for continuing the psychotropic medications and no assessment of the resident's identified target behaviors related to the prescribed medications.
During an interview on 06/23/21 at 12:10 PM, EI #20, Registered Nurse (RN) revealed RI #32 was alert and oriented times three and was up daily to the wheelchair out of his/her room socializing with other residents and staff. EI #20 stated in regard to behaviors, RI #32 had no behaviors such as yelling out, or anything negative towards others or harm to self. EI #20 stated when RI #32 had gone out to the hospital a while back he/she was having hallucinations and was more depressed, but not recently. EI #20 stated the reason the resident was prescribed an antipsychotic was for psychotic behaviors which RI #32 did not have any longer. EI #20 stated RI #32's depression goes up and down and RI #32 would cry a lot at times. EI #20 stated resident behaviors should be monitored daily and documented on the behavioral monitoring sheets kept in the narcotic binder on the medication cart. EI #20 stated sometimes the nurses would chart a behavior in the progress notes under the general note. EI #20 stated she wasn't aware of any recent GDRs related to RI #32's psychotropic medications.
During an interview on 06/23/21 at 1:24 PM, RI #32 revealed he/she was alert and oriented and answered questions accurately and when asked how he/she was doing, RI #32 stated, I'm fine and feel pretty good. RI #32 stated he/she had no concerns related to medications. RI #32 stated the MD had explained the medications that were prescribed, and he/she had understanding of the potential side effects. RI #32 stated he/she had received visits from psych services and had a visit last week with no new recommendations.
During an interview on 06/24/21 at 3:30 PM, EI#2, Director of Nursing (DON) stated in regard to the RI #32's incorrect antipsychotic medication order, EI #2 stated the expectation would be for any physician order that was in conflict with another order should be clarified for accuracy. EI #2 stated it would be the responsibility of the nurses to check physician orders for accuracy.
2. Review of RI#76's undated Face Sheet in the EMR revealed resident was admitted on [DATE] with diagnoses including cellulitis of right below the knee amputation/stump site, muscle weakness, unsteady gait and falls.
Review of R76's quarterly MDS with an ARD of 04/28/21 revealed the BIMS score of 13 which indicated RI#76 had mild cognitive impairments but was capable of making decisions regarding in his/her care. The MDS further documented that RI#76 had no behaviors, no hallucinations, or delusions, and had no active neurological or psychiatric diagnoses. The MDS indicated that RI#76 received antipsychotic medications on five of seven days, an antianxiety medication on six of seven days and an antidepressant medication on seven or seven days.,
In an interview on 06/22/21 at 4:25 PM, EI#12, Licensed Practical Nurse (LPN) stated, [name of resident] settled down since he/she got here .can still be manipulative but used to be out right mean. EI#12 stated RI #76 was aggressive and frequently attempted to hit staff during cares when he/she was admitted .
Review of a physicians progress note found in the MISC. tab of the EMR and dated 02/20/21 revealed that since RI#76's admission to the facility he/she had a gero-psychiatric evaluation on 02/20/21. The psychiatric note revealed RI#76 reported no history of mental health treatment prior to this assessment. Per the 02/20/21 psychiatric progress note the psychiatrist added Trazadone 100mg at bedtime (an antidepressant/sedative medication) to aid in sleep and recommended supportive treatment .follow up 1-2 months . There were no added psychiatric diagnoses; nor were there any follow up psychiatric notes located in RI#76's medical record review . On 06/23/21 at 4:15 PM. EI#2 was asked if there were additional psychiatric notes. She stated, only this one, but I will check again. EI#2 concurred that RI#76 did not have psychiatric diagnosis from either the Medical Director/attending physician or by the psychiatrist.
Review of RI#76's Physician Orders under the Orders tab in the EMR for the months of January 2021 through June 2021 revealed the resident was prescribed the following psychotropic medications by the attending physician/Medical Director (MD):
Prozac (anti-anxiety medication) 20mg daily for depression (not included in diagnoses list)
Seroquel (anti-psychotic medication) 150mg daily for behavioral disturbances and acute agitation. There was no appropriate psychiatric diagnosis for the use of antipsychotics.
Trazadone (antidepressant medication) 150mg at bedtime for depression/sleep
Trileptal (anti-seizure medication) 600mg twice daily for mood. There was no indication in the medical record review that RI#76 had seizures.
Zyprexa (antipsychotic medication) 10mg twice daily for agitation. There was no psychiatric diagnosis for the use of antipsychotic medication.
There were no orders to monitor medication specific adverse effects or to monitor for resident specific target behaviors related to the use of these psychotropic medications. On 06/23/21 at 4:20 PM, EI#2 was asked about behavior monitoring and stated the was no flow sheet, some of the nurse's notes should include behaviors if exhibited, and there was an area on the back of the MAR the nurses could use to document behaviors.
Review of RI#76's nursing progress notes under the Progress Notes tab in the EMR revealed the following: Describe Behavior/Mood, what the resident is doing, interventions attempted and effectiveness.
01/23/21 at 10:51 PM - very hostile behavior .verbally abusive staff .curses frequently . no interventions were included.
02/05/21 at 5:55 PM - resident very hostile .continuous outbursts .much profanity and derogatory and racial remarks to staff. Interventions included a call to the physician and a psychiatric consult was ordered. [Psychiatrist name] contacted and orders received: Seroquel 50mg TID [three times a day]) and Buspar15 mg with meals .
-02/12/21 at 7:00 PM, RI#76 threatened to throw a urinal full of urine at another resident as he/she passed RI#76's room in wheelchair because RI#76 asked for a cigarette from the other resident. No interventions were included.
-03/21/21 - called to lobby by staff - resident was in lobby cussing at staff about food .cussed another resident about cigarettes. Resident redirected was the intervention.
-04/18/21 - the resident was yelling and cussing .CNA [Certified Nurse Aid] found cigarettes and a lighter in resident room and turned into the nurses station. Resident threatening to throw things .and cussing .resident doubled up fist .stated I am going to have your job and say you stole my money and my watch .you should have given those cigarettes to me not the nurse . Intervention was MD notified of behaviors.
-05/09/21 at 4:30 PM .resident came to 4th floor using profanity and yelling at staff .became loud using racial slurs to both black and wite [sic] staff .making sexually inappropriate comments .swung and attempted to hit a female resident confined to a wheelchair. Stated he was going to punch her in the face. MD [name] Administrator and DON notified of behaviors.
Review of the consultant pharmacist's monthly reviews titled, Gradual Dose Reduction Tracking Report from RI#76's admission in January 2021 through the current survey in June 2021 revealed the following:
February 26, 2021 - revealed the pharmacy requested a diagnosis (required for antipsychotics) to support the use of the Seroquel.
March 30, 2021 - again, the pharmacy requested a supporting psychiatric diagnosis.
April 26, 2021 - the request for a supporting diagnosis had still been unanswered.
May 27, 2021 - the physician added an additional antipsychotic (Zyprexa). There continued to be no supporting psychiatric diagnosis to support the use of antipsychotics. Additionally, on this report the pharmacist noted that the MD had also added Prozac on 05/20/21. Prozac is a Selective Serotonin Reuptake Inhibitor/SSRI a psychoactive medication used to treat depression, obsessive-compulsive disorder, bulimia, and panic disorder. There was no documentation in RI#76' medical record of these diagnoses. The MD also added Trileptal on 05/20/21 for mood. Trileptal is an anticonvulsant medication but has been used off label to modify mood/behaviors. Review of RI#76 medical record revealed no diagnoses of mood disorders or of seizures/convulsions. No GDR attempts had been made for R76's psychoactive medications.
During an interview on 06/24/21 at 2:30 PM, RI#76's MD stated he/she reviews the nurse's notes and talks to staff and the residents to make resident care decisions. The MD stated, I manage those medications [psychotropics] unless [psychiatrist name] has decided to make recommendations. The MD further stated that he/she was not sure if he/she had included a written indication for use of each specific psychotropic medication and that he/she was unaware the pharmacy had made multiple requests for an appropriate diagnosis for the use of the antipsychotic medications Seroquel and Zyprexa. The MD stated that he/she was unaware that the facility had no specific behavioral monitoring program and/or policy to assure that residents on psychotropic medications were monitored for specific behaviors (delusions and hallucinations) and/or side effects of psychotropic medications.
3. Review of RI# 75's admission Record located in the EMR indicated the resident was admitted to facility on 01/10/14 with a diagnosis that included but not limited to Alzheimers, dementia without behavioral disturbance, and anxiety disorder.
Review of RI#75's significant change MDS with an ARD of 03/04/21 indicated the resident was moderately impaired with no hallucinations, delusions or any type of behaviors. The resident was not coded as having any psychotic disorders including schizophrenia.
Review of RI#75's Physician Orders located under the Orders Tab of the EMR for May 2021 and June 2021 revealed the resident was prescribed Seroquel, an antipsychotic medication.
Further review of the Physician Order, found under the Orders Tab of the EMR, dated 11/18/20, documented, Seroquel tablet 100 mg. Give one tablet at bedtime related to unspecified Dementia without behavioral disturbance. On 04/13/21 RI#75 was ordered Seroquel tablet 100 mg. Give one 50 mg every morning and at bedtime related to unspecified Dementia without behavioral disturbance.
Review of RI#75's care plan for Potential drug related complication associated with use of psychotic medication, revised on 11/13/20, did not list any non-pharmacological interventions for the resident as well as list any specific behaviors to monitor.
During an interview with EI #15, an LPN, on 06/23/21 at 10:55 AM regarding RI#75's behaviors stated she had not observed any behaviors with RI#75. No hallucination/disorganized speech. Stated the resident had been on Seroquel for a while. EI#15 reviewed the Physician Order stated the resident was just ordered the Seroquel on 05/12/21. EI#15 stated she has been up and down with his/her meds. When asked about what behaviors RI#75 exhibits she stated RI#75 talks to himself/herself but knows he/she is talking to himself/herself so that is the behavior we monitor.
Interview with EI #15 on 06/23/21 at 2:04 PM, stated Social Services has not put the Behavioral Monitoring Flowsheets out for this month. She stated the old flowsheet can be found in the paper chart. EI#15 also stated behaviors are documented on the MAR. When asked how you know which behaviors to observe, she indicated the Behavior Monthly Flowsheet.
Review of the paper chart revealed the only Behavior Monthly Flowsheet was last dated February 2021. The behavior code for monitoring indicated, 12. Depression/Withdrawn and 17. Hallucinations paranoia/ delusions There was no Behavior Monthly Flowsheet for the months March, April, May and June 2021.
Review of RI#75's, Progress Notes, found under the Notes Tab of the EMR, from January 2021 until June 2021 revealed the following:
Weekly note, dated 03/25/21- . Have conversation with self at intervals. Frequently yelling out ghost busters .
04/13/21- Behavior Charting revealed - Resident has noted change in behaviors all throughout the day, increased agitation with attempting to redirect him/her, becomes more aggressive with the staff and other residents, excessive eating throughout the day, yelling out, medications not effective and attempted to get on the elevator to leave the facility, looking for his/her sister, MD has been notified of increased behaviors.
Further review of RI#75's Progress Notes located in the EMR, indicated from 04/15/21 to 06/23/21, the question Was a behavior observed? Answered Yes. There was no additional documentation indicating what behavior was observed.
Review of the most recent Psych Note found in the paper medical record, dated 02/19/21, indicated no symptoms of suicidal idealities, auditory/visual hallucinations, or delusions.
During an interview with the Consultant Pharmacist, on 06/24/21 at 12:09 PM, she stated on April 26, 2021, she completed a recommendation to clarify the diagnosis of dementia without behavioral disturbance and to change the diagnosis to dementia with behavioral disturbances if RI #75 was having behaviors. When asked if she thought the diagnosis was appropriate indication for use [for the antipsychotic], the Consultant Pharmacist said she thought so if the resident is on an antipsychotic for dementia with behavioral disturbance.
During an interview with EI#2 on 06/24/21 at 2:18 PM, in regard to the resident being on an antipsychotic without appropriate indication. EI#2 stated, in our population we have residents with dementia on antipsychotic medication that if they were not, they could potentially be a threat to themselves and others. RI#75 falls into that category when he/she is off his/her medication. Our Behavior Monitoring is in our nursing notes or our point of care document. We do have Behavior Monitoring Flowsheets for residents on psych meds and they are put in the chart by our Social Worker and nursing document on them. The form should be put out for nursing at the beginning of the month, and it is collected at the end of the month and returned to the Social Worker for review. The form should never go back into the medical chart. EI#2 was informed there was no Behavior Monitoring Flowsheet for the Month of June currently for nursing to document on. EI#2 confirmed there were no additional flowsheets for RI#75.
Interview with the MD on 06/24/21 at 3:03 PM, in regard to the indication for use for the Seroquel, the MD stated, no dementia is not an indication for use.
4. Review of RI #18's undated Face Sheet in the EMR revealed RI #18 was admitted on [DATE] with diagnoses of adjustment disorder with depressed mood, unspecified dementia with behavioral disturbance, anxiety disorder due to known physiological condition, traumatic brain injury.
Review of RI #18's admission MDS with an ARD dated 03/09/21 revealed RI #18 has a BIMS score of 11 which indicates resident was moderately cognitively impaired with no behaviors. RI #18 received anti-psychotic medication during the assessment period.
Review of RI #18's Physician Orders included the following:
03/19/20- Seroquel 100 mg tablet give 1 tablet by mouth three time a day related to anxiety disorder due to known physiological condition. There was no indication for use listed for this antipsychotic medication.
03/19/20 - Seroquel 150 mg tablet take one tablet by mouth at bedtime related to unspecified dementia with behavioral disturbance. There was no indication for use listed.
Review of the manufacturer's guidelines for the Seroquel revealed that they were to treat specific conditions, which did not include dementia, anxiety, and agitation. In addition, use of these medications for residents with dementia placed the resident at increased risk of death. These guidelines included:
Review of the manufacturer's guidelines for the use of the medication Seroquel last updated 10/20 revealed, .Approved Uses Seroquel is a once-daily tablet approved in adults for major depressive disorder (MDD) who did not have an adequate response to antidepressant therapy; bipolar disorder; acute manic or mixed episodes in bipolar disorder alone or with lithium or divalproex; long-term treatment of bipolar disorder with lithium or divalproex; and schizophrenia .Elderly patients with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) treated with this type of medicine are at an increased risk of death, compared to placebo (sugar pill). Seroquel is not approved for treating these patients .
During an interview on 06/24/21 at 3:55 PM, EI #2, stated he/she could not locate the GDR request documentation made by the pharmacist (dated 08/11/20, 12/16/20 and 04/26/21) for RI #18.
Review of the manufacturer's guidelines for the use of the medication Seroquel last updated 10/20 revealed, .Approved Uses Seroquel is a once-daily tablet approved in adults for major depressive disorder (MDD) who did not have an adequate response to antidepressant therapy; bipolar disorder; acute manic or mixed episodes in bipolar disorder alone or with lithium or divalproex; long-term treatment of bipolar disorder with lithium or divalproex; and schizophrenia .Elderly patients with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) treated with this type of medicine are at an increased risk of death, compared to placebo (sugar pill). Seroquel is not approved for treating these patients .
Review of the undated facility's policy titled, Antipsychotic Reduction Guide revealed the facility would establish a quality committee to monitor all antipsychotic medications at least monthly and consider tapering or discontinuing the use of antipsychotic medication in the residents that do not exhibit behaviors.
The facility provided a letter dated 06/23/21 stating they have no psychotropic medication policy.
CONCERN
(F)
Potential for Harm - no one hurt, but risky conditions existed
Food Safety
(Tag F0812)
Could have caused harm · This affected most or all residents
Based on observation, interview, record review and facility policy review, the facility failed to ensure the kitchen staff adhered to safe practices to prevent the potential spread of food-borne illne...
Read full inspector narrative →
Based on observation, interview, record review and facility policy review, the facility failed to ensure the kitchen staff adhered to safe practices to prevent the potential spread of food-borne illness to all residents who received their meals from the kitchen. Concerns were noted with dish-washing procedures, sanitizing solution concentrations, cleaning contact surfaces after exposure to raw meat, failure to remove significantly dented cans from the general canned food supply, and cleanliness in the dry food store room.
Findings include:
1. On 06/21/21 from 10:40 AM - 11:05 AM, the three-sink pot washing sinks were in use, each filled with a separate solution (wash, rinse, sanitize). There were multiple pots on counter drying next to the third sink. Employee Identifier (EI)#9, Diet Tech (kitchen manager) used a quaternary ammonia test strip to check the level of the sanitizing solution in the third sink. The test strip did not register any parts per million (PPM) of the sanitizer. EI#9, asked EI#11,Cook, who was in the vicinity to drain the sink and refill it. EI#9 asked EI#11 why there was no sanitizer present in the third sink. EI#11 stated he did not know.
2. On 06/23/21 at 10:05 AM, EI#10, Cook, prepared the pureed pork chops for the noon meal. EI #10 first took a steam table pan full of boneless pork chops and watery fluid and drained the fluid off the meat, pouring it down the left side of the food preparation sink. There were two food prep sinks right next to each other. EI#10 then placed the pork chops into the Robot Coupe commercial food processor and took the steam table pan to the three-sink pot washing area. After blenderizing the pork chops, he/she washed the pan that held the pork chops in the food preparation sink, dunked it in the rinse solution in the second sink, and then dunked it in the sanitizer solution in the third sink. He/she then brought the pan back to where he/she prepared the pureed pork chops. He/she did not immerse the pan in the third sink for more than a second when he/she dunked it. EI#10 then poured the pureed pork chops into this steamtable pan and reheated the mixture to bring it up to temperature for serving. EI#9 was notified of the observation at this time and stated that the pots should be immersed in the third sink sanitizer solution but would have to check on how much time the pots should be immersed.
3. On 06/23/21 at approximately 10:12 AM, EI#11 took a batch of raw pork chops and placed them in the food preparation sink and kneaded the pork chops with a spice mixture. After the pork chops were removed, he/she wiped out the sink with a wiping rag from the sanitizer bucket without washing the sink first with soap/detergent. EI#11 was interviewed at the time and stated he/she used the rag that was in the sanitizing solution to wipe out the sink and had not washed the sink first with soap or detergent.
Review of the facility's policy titled, Dietary Food Handling with an effective date of 01/01/17, from the DMS Policy & Procedure Food Service Manual, revealed, It is the policy of this center to provide guidelines for the safe preparation, handling and storage of perishable foods and proper environmental cleaning .Each time there is a change in processing from raw to ready to-eat foods, each new operation should begin with clean and sanitized food contact surfaces and utensils .
Review of the facility's policy titled, Pots and Pans with an effective date of 08/01/12, from the DMS Policy & Procedure Food Service Manual, revealed it was the policy of the facility to, clean and sanitize pots and pans to maintain sanitary food preparation, service and delivery environment .The three-sink system is preferred if the dishwashing machine is not used. For three-sink system: In Sink No [number] 1 [wash sink] prepare a hot solution of facility approved cleaner. Sink No. 11 [Rinse Sink] should be a clear, hot water rinse. In Sink No. III [Sanitizing Sink], prepare a solution of the facility approved sanitizer and hot water. After pre-soak/wash, excess soil was to be scraped, all surfaces were to e scrubbed, the item was to be immersed in the rinse sink and then immersed in the sanitizing sink following manufacturer instructions for sanitizer.
Review of the Manufacturer's Instructions titled, Auto Chlor System, Dishwashing Three Sink Method instructions, revealed the system included wash [clean water and detergent], rinse [clean water], and sanitizing [clean water and sanitizer] solutions be used in that order. Food contact surfaces sanitizing called for a solution between 200 - 400 PPM of the sanitizer [quaternary ammonia]. The product label was to be consulted for the required contact time [of the sanitizer]. Review of the product label revealed thorough washing was to occur prior to sanitizing. The treated surfaces must remain wet for 60 seconds [with the sanitizer solution].
4. During the initial kitchen inspection with EI#9 on 06/21/21, from 10:40 AM - 11:05 AM, the dry store room was observed. There was a #10 can in the general can rack with a dent of approximately one - two inches along the bottom seal of the can. In addition, there was a window sill that had dirt, debris and contained approximately five dead bugs. There were also multiple spider webs in the window sill area. There was canned food on a shelf in the window near the window sill.
5. During a second observation with EI#9 on 06/23/21 at 9:24 AM, in the dry store room there was a dented #10 can noted on 06/21/21 (apple pie filling) and there were three significantly dented #10 cans of peaches with large dents along the bottom seal. The cans were disfigured from the large dents. EI#9 stated the staff member who put away the last order should not have put the peaches on shelf with canned goods that were to be used. He/she stated the dented cans were supposed to be placed on a separate shelf and it was supposed to be labeled (although it was not) with a sign for dented cans. The window sill was in the same condition noted on 06/21/21 with approximately five dead bugs, multiple spider webs, and cans of soup and olives stored on shelf near the window sill. EI#9 stated the area needed to be cleaned.
Review of the facility's policy titled, Dry Storage with an effective date of 01/01/17, from the DMS Policy & Procedure Food Service Manual, revealed, It is the policy of this center to store, prepare and serve food that is stored in accordance with federal, state, and local sanitary codes . The floors, walls, shelves, and equipment in the storeroom will be kept clean and in good repair . The storeroom will be kept free from insects and rodents . Leaking cans and spoiled food will be removed promptly. Damaged cans will be identified for removal . Damaged canned food containers will be stored together in the storeroom in a separate and distinct area away from other food items. This area should be labeled. The damaged food containers will be returned to the vendor .Damaged containers are defined as: a. all dented containers (other than those with a slight to moderate dent that does not involve the seam and does not rock on a flat surface) .
Review of the facility's policy titled, Equipment Cleaning Schedules with an effective date of 08/01/12, from the DMS Policy & Procedure Food Service Manual, revealed, It is the policy of this facility to assign cleaning schedules on a daily, weekly and monthly basis. The policy indicated the dry store room was scheduled for weekly cleaning.
6. On 06/23/21 at approximately 10:24 AM, a dietary aide was observed removing clean dishes from the commercial dish machine. He/she wiped out a small, clean bowl with a dry rag and stacked it with the clean dishes.
Review of the Food Code U.S. Public Health Service, Food and Drug Administration, College Park MD, 2017 indicates, Drying 4-901.11 Equipment and Utensils, Air-Drying Required. Items must be allowed to drain and to air-dry before being stacked or stored. Stacking wet items such as pans prevents them from drying and may allow an environment where microorganisms can begin to grow. Cloth drying of equipment and utensils is prohibited to prevent the possible transfer of microorganisms to equipment or utensils.
During an interview on 06/24/21 at 4:47 PM, EI#8, Registered Dietitian (RD), stated dented cans should be placed in a separate area (distinct from the general can storage area). EI#8 stated the sanitizer level for quaternary ammonia sanitizer should be between 200-400 PPM. Regarding immersion of pots/pans in the sanitizer solution in the third sink for pot washing, he/she stated items should be immersed, but the manufacturer's information did not document an exact time and instead it indicated the items should be immersed or remain wet for 60 seconds. EI#8 stated he/she had gone by 30 - 60 seconds timeframe for how long pots should be immersed in the third sink sanitizer solution. When notified of the food preparation sink with raw meat and wiping it with a wiping rag that was in the sanitizing solution prior to washing the sink first, she/he stated the sink should be washed first and then staff should sanitize it. EI#8 stated dishes should be air dried when they were removed from the dish machine and should not be dried with towels.